Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
RIVERSTONE HOLDINGS LLC PR Permian Resources Corp 13D/A 6.7% 2y
Charles W. Ergen ECHO EchoStar CORP 13D/A 54% 2y
Bayshore Capital LLC WULF Terawulf Inc. 13D/A 6% 2y
Harraden Circle Investments, LLC BFAC Battery Future Acquisition Corp. 13G 8.7% 2y
BOXER CAPITAL, LLC ITOS iTeos Therapeutics, Inc. Common Stock 13D/A 8.1% 2y
Amster Howard WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 16.6% 2y
Topline Capital Management, LLC ACCS ACCESS Newswire Inc. 13G/A 15.9% 2y
Harraden Circle Investments, LLC GPAT GP-Act III Acquisition Corp. 13G 7.5% 2y
BCM Investimentos Fundo de Investimento Multimercado Crédito Privado Investimento no Exterior CLVR Clever Leaves Holdings Inc. Common Shares 13D 8.5% 2y
A.L. Sarroff Fund, LLC PETV PetVivo Holdings, Inc. 13G/A 16.21% 2y
Christopher Savoie ZPTA Zapata Quantum, Inc. 13G 5% 2y
Caledonia (Private) Investments Pty Ltd LAWIL Light & Wonder, Inc. 13G/A 9.46% 2y
Lind Global Fund II LP SNES SenesTech, Inc. 13G/A 9.9% 2y
MHR FUND MANAGEMENT LLC TSAT Telesat Corp 13D/A 36.2% 2y
Michele D. Logan GPGI GPGI, Inc. 13D/A 23.1% 2y
MHR FUND MANAGEMENT LLC TWI Titan International Inc 13D/A 11.3% 2y
Jeffrey Wolf SCPX Scorpius Holdings, Inc. 13D/A 10.5% 2y
LLR Capital IV, L.P. GPGI GPGI, Inc. 13D/A 36.94% 2y
NOVO HOLDINGS A/S IOBTQ IO Biotech, Inc. 13G/A 10.1% 2y
Piton Capital Partners LLC ASYS Amtech Systems Inc 13D/A 19.2% 2y
Mill Road Capital III, L.P. ALTG Alta Equipment Group Inc. 13D/A 9.8% 2y
Artal International S.C.A. LXRX Lexicon Pharmaceuticals, Inc. 13D/A 48.4% 2y
FINDELL CAPITAL MANAGEMENT LLC OPRT Oportun Financial Corp 13D/A 9.7% 2y
Ernest C. Garcia II CVNA Carvana Co. 13D/A 42.2% 2y
Mitchell P. Kopin HSDT Solana Co 13G 4.99% 2y
MILLENNIUM MANAGEMENT LLC MRVI Maravai Lifesciences Holdings, Inc. 13G 5.4% 2y
Jason Gardner MQ Marqeta, Inc. 13G/A 10.7% 2y
Ezra Dabah PIK Kidpik Corp. Common Stock 13D/A 65.3% 2y
Aleksander Migon BASE Couchbase, Inc. Common Stock 13G/A 6.4% 2y
Cove Street Capital, LLC RSSS Research Solutions, Inc. 13D/A 8.64% 2y
BAKER BROS. ADVISORS LP INCY Incyte Corp 13D/A 16.3% 2y
Stanley Kesselman CVR Chicago Rivet & Machine Co 13G 5% 2y
Hill Path Capital LP PRKS United Parks & Resorts Inc. 13D/A 43.6% 2y
Patel Tushar Bhikhubhai AMRX Amneal Pharmaceuticals, Inc. 13D/A 17.4% 2y
New Enterprise Associates 16, L.P. BDTX Black Diamond Therapeutics, Inc. 13D/A 8.1% 2y
Madryn Asset Management, LP GBNH Greenbrook TMS Inc. Common Shares 13D/A 61.2% 2y
New Enterprise Associates 17, L.P. GLUE Monte Rosa Therapeutics, Inc. 13D/A 15.4% 2y
Nathan D. Hukill TTOO T2 Biosystems, Inc 13D/A 69.5% 2y
Hoak Public Equities, LP WHG Westwood Holdings Group Inc 13D/A 7.8% 2y
The Westaim Corporation SKWD Skyward Specialty Insurance Group, Inc. 13G/A 4.8% 2y
Saba Capital Management, L.P. ECF Ellsworth Growth & Income Fund Ltd 13D 5.32% 2y
SUVRETTA CAPITAL MANAGEMENT, LLC ABEO Abeona Therapeutics Inc. 13G 9.3% 2y
Cormorant Asset Management, LP CTMX CytomX Therapeutics, Inc. 13G 7.38% 2y
Avidity Partners Management LP CNTX Context Therapeutics Inc. 13G 9.9% 2y
MMCAP International Inc. SPC CCIX Churchill Capital Corp IX 13G 6.1% 2y
S.H.N. Financial Investments Ltd. CETX Cemtrex Inc 13G 9.99% 2y
Allostery Investments LP AVTX Avalo Therapeutics, Inc. 13G 7.6% 2y
SAMLYN CAPITAL, LLC CRVS Corvus Pharmaceuticals, Inc. 13G/A 9.99% 2y
Anette Schmid SHMD SCHMID Group N.V. 13D 30.3% 2y
PERCEPTIVE ADVISORS LLC BDSX Biodesix Inc 13G 5.6% 2y